Merck, Pfizer pull the plug on ovarian cancer trial
admin 20th March 2019 Uncategorised 0Merck and Pfizer are pulling the plug on a late-stage trial assessing the potential of their PD-L1 antibody avelumab in the front-line maintenance setting for ovarian cancer. More: Merck, Pfizer pull the plug on ovarian cancer trial Source: News
read more